Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
CanadaBis Capital, Inc. ( (TSE:CANB) ) just unveiled an announcement.
Canadabis Capital has achieved a significant milestone with the first shipment of Stigma Grow’s premium cannabis products to Portugal, marking the company’s entry into the European market. This move aligns with the increasing demand for high-quality cannabis products in Portugal and underscores Stigma Grow’s commitment to expanding its global presence. The successful entry into Portugal highlights the company’s strategic planning and dedication to innovation, positioning Canadabis Capital and Stigma Grow as leaders in the cannabis industry as they pursue further international opportunities.
More about CanadaBis Capital, Inc.
Stigma Grow is a forward-thinking cannabis cultivation and extraction company known for its innovative products that challenge the norms of the legal cannabis industry in Canada. Positioned to address unmet market demands, the company focuses on quality, sustainability, and community engagement.
YTD Price Performance: 0%
Average Trading Volume: 91,516
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$8.3M
Find detailed analytics on CANB stock on TipRanks’ Stock Analysis page.
